/target-data-sheets/checkpoint/cd86
6/1/2016 6:21:05 AM
/products/cell-line/u2os-cd86-ligand-cell-line-93-1093c3
Despite the recent clinical success of T cell checkpoint inhibition targeting the CTLA-4 and PD-1 pathways, many patients either fail to achieve objective responses or they develop resistance to therapy. In some cases, poor responses to checkpoint blockade have been linked t...
/tools-resources/publications-references/publications/the-engineered-cd80-variant-fusion-therapeutic-dav
5/24/2022 11:38:03 PM
/products/reagent/anti-ctla4-antibody-14d3-92-1319
/products/cell-line/jurkat-ctla4-signaling-cell-line-93-1094c19
/products/cell-line/jurkat-cd28-signaling-cell-line-93-1126c19